141 related articles for article (PubMed ID: 2438496)
1. Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors.
Unger T; Ganten D; Lang RE
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S75-81. PubMed ID: 2438496
[TBL] [Abstract][Full Text] [Related]
2. Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications.
Unger T; Ganten D; Lang RE
Am J Cardiol; 1987 Apr; 59(10):18D-22D. PubMed ID: 3034027
[TBL] [Abstract][Full Text] [Related]
3. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.
Unger T; Ganten D; Lang RE; Schölkens BA
J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494
[TBL] [Abstract][Full Text] [Related]
4. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
Unger T; Gohlke P
Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
[TBL] [Abstract][Full Text] [Related]
5. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D
Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
[TBL] [Abstract][Full Text] [Related]
6. Tissue converting enzyme inhibition and cardiovascular effects of converting enzyme inhibitors.
Unger T; Schölkens BA; Ganten D; Lang RE
Clin Exp Hypertens A; 1987; 9(2-3):417-26. PubMed ID: 3038405
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Moursi MG; Ganten D; Lang RE; Unger T
J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
[TBL] [Abstract][Full Text] [Related]
8. From tissue angiotensin converting enzyme inhibition to antihypertensive effect.
Veltmar A; Gohlke P; Unger T
Am J Hypertens; 1991 Mar; 4(3 Pt 2):263S-269S. PubMed ID: 2043316
[TBL] [Abstract][Full Text] [Related]
9. Converting enzyme inhibitors and their effects on the renin-angiotensin system of the blood vessel wall.
Unger T; Gohlke P; Ganten D; Lang RE
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S8-16. PubMed ID: 2474111
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems.
Lee MA; Paul M; Böhm M; Ganten D
Am J Cardiol; 1992 Oct; 70(10):12C-19C. PubMed ID: 1414888
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).
Unger T; Moursi M; Ganten D; Hermann K; Lang RE
J Cardiovasc Pharmacol; 1986; 8(2):276-85. PubMed ID: 2422465
[TBL] [Abstract][Full Text] [Related]
12. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats.
Unger T; Ganten D; Lang RE; Schölkens BA
J Cardiovasc Pharmacol; 1985; 7(1):36-41. PubMed ID: 2580148
[TBL] [Abstract][Full Text] [Related]
13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
14. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
[TBL] [Abstract][Full Text] [Related]
15. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
Harrap SB; Van der Merwe WM; Griffin SA; Macpherson F; Lever AF
Hypertension; 1990 Dec; 16(6):603-14. PubMed ID: 2246027
[TBL] [Abstract][Full Text] [Related]
16. Central effects of converting enzyme inhibitors.
Schölkens BA; Xiang JZ; Unger T
Clin Exp Hypertens A; 1983; 5(7-8):1301-17. PubMed ID: 6315270
[TBL] [Abstract][Full Text] [Related]
17. Mechanism and pressor relevance of the short-term cardiovascular and renin excitatory actions of the selective A2A-adenosine receptor agonists.
Alberti C; Monopoli A; Casati C; Forlani A; Sala C; Nador B; Ongini E; Morganti A
J Cardiovasc Pharmacol; 1997 Sep; 30(3):320-4. PubMed ID: 9300315
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288.
Gohlke P; Schölkens B; Henning R; Urbach H; Unger T
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S32-6. PubMed ID: 2483426
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic, but not low-dose, angiotensin-converting enzyme inhibition causes regression of cardiovascular changes in spontaneously hypertensive rats.
Wahlander H; Sohtell M; Wickman A; Nilsson A; Friberg P
J Cardiovasc Pharmacol; 1996 Mar; 27(3):327-34. PubMed ID: 8907793
[TBL] [Abstract][Full Text] [Related]
20. Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension.
Weber MA
Am J Hypertens; 1999 Dec; 12(12 Pt 3):189S-194S. PubMed ID: 10619571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
